111 related articles for article (PubMed ID: 8911678)
21. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease.
Villar-Cheda B; Rodríguez-Pallares J; Valenzuela R; Muñoz A; Guerra MJ; Baltatu OC; Labandeira-Garcia JL
Eur J Neurosci; 2010 Nov; 32(10):1695-706. PubMed ID: 20964730
[TBL] [Abstract][Full Text] [Related]
22. Amphetamine induces excess release of striatal acetylcholine in vivo that is independent of nigrostriatal dopamine.
Mandel RJ; Leanza G; Nilsson OG; Rosengren E
Brain Res; 1994 Aug; 653(1-2):57-65. PubMed ID: 7982076
[TBL] [Abstract][Full Text] [Related]
23. Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection.
O'Dell SJ; Gross NB; Fricks AN; Casiano BD; Nguyen TB; Marshall JF
Neuroscience; 2007 Feb; 144(3):1141-51. PubMed ID: 17157992
[TBL] [Abstract][Full Text] [Related]
24. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Holmer HK; Keyghobadi M; Moore C; Meshul CK
Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
[TBL] [Abstract][Full Text] [Related]
25. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.
McArthur S; Murray HE; Dhankot A; Dexter DT; Gillies GE
J Neurochem; 2007 Feb; 100(3):678-92. PubMed ID: 17116232
[TBL] [Abstract][Full Text] [Related]
26. Protection of methamphetamine nigrostriatal toxicity by dietary selenium.
Kim HC; Jhoo WK; Choi DY; Im DH; Shin EJ; Suh JH; Floyd RA; Bing G
Brain Res; 1999 Dec; 851(1-2):76-86. PubMed ID: 10642830
[TBL] [Abstract][Full Text] [Related]
27. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
28. Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice.
Dluzen DE; McDermott JL; Anderson LI
J Neuroendocrinol; 2001 Jul; 13(7):618-24. PubMed ID: 11442776
[TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
[TBL] [Abstract][Full Text] [Related]
30. Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120).
Herzog CD; Brown L; Kruegel BR; Wilson A; Tansey MG; Gage FH; Johnson EM; Bartus RT
Neurobiol Dis; 2013 Oct; 58():38-48. PubMed ID: 23631873
[TBL] [Abstract][Full Text] [Related]
31. Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats.
Chandra G; Gangopadhyay PK; Senthil Kumar KS; Mohanakumar KP
Brain Res; 2006 Feb; 1075(1):81-92. PubMed ID: 16487496
[TBL] [Abstract][Full Text] [Related]
32. Opioid peptides alleviated while naloxone potentiated methamphetamine-induced striatal dopamine depletion in mice.
Yu L; Kuo YM; Cherng CF
J Neural Transm (Vienna); 2001; 108(11):1231-7. PubMed ID: 12030189
[TBL] [Abstract][Full Text] [Related]
33. Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
Liu B; Dluzen DE
Synapse; 2006 Oct; 60(5):354-61. PubMed ID: 16838362
[TBL] [Abstract][Full Text] [Related]
34. MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra.
Zuddas A; Corsini GU; Schinelli S; Johannessen JN; di Porzio U; Kopin IJ
Brain Res; 1989 Oct; 501(1):1-10. PubMed ID: 2572305
[TBL] [Abstract][Full Text] [Related]
35. A new poly(ADP-ribose) polymerase inhibitor, FR261529 [2-(4-chlorophenyl)-5-quinoxalinecarboxamide], ameliorates methamphetamine-induced dopaminergic neurotoxicity in mice.
Iwashita A; Mihara K; Yamazaki S; Matsuura S; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Sep; 310(3):1114-24. PubMed ID: 15113847
[TBL] [Abstract][Full Text] [Related]
36. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
[TBL] [Abstract][Full Text] [Related]
37. Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra.
Costa G; Abin-Carriquiry JA; Dajas F
Brain Res; 2001 Jan; 888(2):336-342. PubMed ID: 11150495
[TBL] [Abstract][Full Text] [Related]
38. Selective ablation of striatal striosomes produces the deregulation of dopamine nigrostriatal pathway.
Shumilov K; Real MÁ; Valderrama-Carvajal A; Rivera A
PLoS One; 2018; 13(8):e0203135. PubMed ID: 30157254
[TBL] [Abstract][Full Text] [Related]
39. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
[TBL] [Abstract][Full Text] [Related]
40. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR
Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
